Gain detailed insights into the trading activity of Congress members for Carl Zeiss Meditec on our government trades page. Stay updated on how elected officials are investing in CZMWY.

Carl Zeiss Meditec - Government Trades

CARL ZEISS MEDITEC

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Analyst Color

Long Ideas

News

Short Ideas

Health Care

Initiation

Analyst Ratings

Movers

Trading Ideas

General

CZMWY

Innovation and digitalization have been in focus among ophthalmology majors.

Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: &#39;Innovation Is Key&#39;

Emerging Markets

Small Cap

Markets

TOPCF

Vision is the most cherished of the five senses. Losing your eyesight can have a tremendously debilitating impact on your day-to-day life.

24% of American Dont Have Vision Care: Here&#39;s Why

Tech

Image provided by Retina Technologies

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Technology That Could Catch Vision Problems Early And Save Your Eyesight?

Picture credit: Mari Lezhava on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Retina Technologies Says It&#39;s Looking To Make Eye Care More Accessible, Especially For Those Traditionally Underserved

Intraday Update

ACGLO

ACGLP

ACOPF

ACRL

AHNR

AKRO

ALMFF

AMAT

AMYZF

ANSS

APHD

ARCAY

ARCT

ARNGF

ASMIY

ASML

ASMLF

AUDC

BALMF

BGAVF

BHPBF

BKRRF

BPYPP

BYND

CAGDF

CHMA

CHOLF

CKDXY

CMPGY

CNMF

CNNB

CPRT

CRVL

CRWD

CVAS

DCGD

DISH

DRGDF

DYFSF

New Oriental Education & Technology Group

EFIN

ENPH

ESGRO

ESGRP

FALC

FRRVY

FTMNF

GKPRF

GNBT

GNCGF

GNRC

GNTX

HCHDF

HGKGY

IBERIABANK Corporation - Depositary Shares Representing Series B Fixed to Floating

IBKCP

ICGUF

IEHC

INGIY

IPHI

ISCB

ISDAY

ISVLF

JYNT

KDKN

KELYA

KGTFY

KLAC

KNTNF

KRYS

KTOS

LMEFF

LPLA

LRAD

LRCX

LSYN

LZAGF

Stocks that Broke 52-Week Highs Tuesday

CARL ZEISS MEDI UNSP/ADR by Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

Press Releases

ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market

ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions

ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.

ZEISS introduces its latest Robotic Visualisation System for neuro surgery

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

CZMWF

Carl Zeiss Meditec

Government Trades

Carl Zeiss Meditec AG

top performing CZMWY trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga